92 related articles for article (PubMed ID: 18077083)
1. Germline alterations in the CLSPN gene in breast cancer families.
Erkko H; Pylkäs K; Karppinen SM; Winqvist R
Cancer Lett; 2008 Mar; 261(1):93-7. PubMed ID: 18077083
[TBL] [Abstract][Full Text] [Related]
2. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer.
Karppinen SM; Erkko H; Reini K; Pospiech H; Heikkinen K; Rapakko K; Syväoja JE; Winqvist R
Eur J Cancer; 2006 Oct; 42(15):2647-52. PubMed ID: 16930991
[TBL] [Abstract][Full Text] [Related]
3. Germline BRCA1 mutation and survival analysis in familial breast cancer patients in Kerala; South India.
Vinodkumar B; Syamala V; Abraham EK; Balakrishnan R; Ankathil R
J Exp Clin Cancer Res; 2007 Sep; 26(3):329-36. PubMed ID: 17987791
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
5. A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer.
Gajalakshmi P; Natarajan TG; Selvi Rani D; Thangaraj K
Breast Cancer Res Treat; 2007 Jan; 101(1):3-6. PubMed ID: 17131039
[TBL] [Abstract][Full Text] [Related]
6. No germline FH mutations in familial breast cancer patients.
Kiuru M; Lehtonen R; Eerola H; Aittomäki K; Blomqvist C; Nevanlinna H; Aaltonen LA; Launonen V
Eur J Hum Genet; 2005 Apr; 13(4):506-9. PubMed ID: 15523491
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436
[TBL] [Abstract][Full Text] [Related]
8. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
[TBL] [Abstract][Full Text] [Related]
9. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor genes and their alterations in breast cancer.
Lee EY
Semin Cancer Biol; 1995 Jun; 6(3):119-25. PubMed ID: 7495979
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin.
Zhang J; Song YH; Brannigan BW; Wahrer DC; Schiripo TA; Harris PL; Haserlat SM; Ulkus LE; Shannon KM; Garber JE; Freedman ML; Henderson BE; Zou L; Sgroi DC; Haber DA; Bell DW
Mol Cancer Res; 2009 Sep; 7(9):1510-6. PubMed ID: 19737971
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis and characterization of HSD17B2 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer.
Plourde M; Manhes C; Leblanc G; Durocher F; Dumont M; Sinilnikova O; ; Simard J
J Mol Endocrinol; 2008 Apr; 40(4):161-72. PubMed ID: 18372405
[TBL] [Abstract][Full Text] [Related]
14. Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.
Solyom S; Winqvist R; Nikkilä J; Rapakko K; Hirvikoski P; Kokkonen H; Pylkäs K
Cancer Lett; 2011 Mar; 302(2):113-8. PubMed ID: 21236561
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
16. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
[TBL] [Abstract][Full Text] [Related]
17. The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer.
Wirtenberger M; Schmutzhard J; Hemminki K; Meindl A; Sutter C; Schmutzler RK; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2007 Feb; 28(2):423-6. PubMed ID: 16956908
[TBL] [Abstract][Full Text] [Related]
18. A BRCA2 mutation, 4088insA, in a Finnish breast and ovarian cancer family associated with favourable clinical course.
Hartikainen JM; Mannermaa A; Heinonen S; Kosma VM; Kataja V
Anticancer Res; 2007; 27(6C):4295-300. PubMed ID: 18214034
[TBL] [Abstract][Full Text] [Related]
19. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of novel presenilin-2 variants identified in human breast cancers.
To MD; Gokgoz N; Doyle TG; Donoviel DB; Knight JA; Hyslop PS; Bernstein A; Andrulis IL
Oncogene; 2006 Jun; 25(25):3557-64. PubMed ID: 16474849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
